SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form C/A - Offering Statement: [Amend]
SEC Accession No. 0001669191-20-000057
Filing Date
2020-02-18
Accepted
2020-02-18 11:54:10
Documents
14

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C/A  
1 primary_doc.xml C/A 9948
2 OFFERING STATEMENT PDF offeringstatement.pdf EX-99 139534
3 OFFERING PAGE JPG offeringpage.jpg GRAPHIC 1976980
4 INCOME STATEMENT income.pdf EX-99 122601
5 BALANCE SHEET balancesheet.pdf EX-99 249199
6 CASH FLOW STATEMENT cashflow.pdf EX-99 396022
7 CHANGE IN EQUITY STATEMENT changeinequity.pdf EX-99 220874
8 CPA AUDIT REPORT auditreport.pdf EX-99 298508
9 PRINCIPAL EXECUTIVE CERTIFICATION executivecertification.pdf EX-99 60018
10 CERTIFICATE OF INCORPORATION certificateofincorporation.pdf EX-99 12718331
11 CORPORATE BYLAWS corporatebylaws.pdf EX-99 95547
12 PITCH DECK pitchdeck.pdf EX-99 1167610
13 ADDITIONAL INFORMATION otherfinancial.pdf EX-99 140687
14 IMAGE ATTACHMENTS HTML imageattachments.htm EX-99 245
  Complete submission text file 0001669191-20-000057.txt   24220994
Mailing Address 16776 BERNARDO CENTER DRIVE #203 SAN DIEGO CA 92128
Business Address 16776 BERNARDO CENTER DRIVE, SUITE 203 SAN DIEGO CA 92128 8584516173
Global Cancer Technology, Inc. (Filer) CIK: 0001743261 (see all company filings)

IRS No.: 461785241 | State of Incorp.: NV | Fiscal Year End: 1231
Type: C/A | Act: 33 | File No.: 020-25769 | Film No.: 20624200
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences